20 hrs ago
Translation of Genetics Research to Clinical Medicine: The National...
From the Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute , and Division of Cancer Control and Population Sciences , National Cancer Institute, Bethesda, MD.
Mon Dec 16, 2013
Nuvilex to Answer Increasing Calls for Better Pancreatic Cancer Treatment Without Gemcitabine
Nuvilex, Inc. may be just what the National Cancer Institute and a growing number of doctors ordered - the company's late stage clinical trials in advanced, inoperable pancreatic cancer that is.
Fri Dec 13, 2013
CTG Ranks in Top Third of InformationWeek 500 Business Innovation List
CTG , an IT solutions and services company, announced today that it placed 132, putting it in the top third, on the 25 annual InformationWeek 500 list of the country's most innovative users of business technology.
Additional drug shows promise for women with triple-negative breast cancer
In a nationwide study of women with "triple-negative" breast cancer, adding the chemotherapy drug carboplatin or the angiogenesis inhibitor Avastin to standard chemotherapy drugs brought a sharp increase in the number of patients whose tumors shrank away completely, investigators will report at the 2013 San Antonio Breast Cancer Symposium.
Boehringer Ingelheim Pharmaceuticals Inc. Earns CEO Cancer Gold Standard Accreditation
The CEO Roundtable on Cancer has awarded Boehringer Ingelheim with CEO Cancer Gold Standard TM accreditation for its efforts to reduce the risk of cancer for its employees and covered family members by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment.
Thu Dec 12, 2013
Study Finds No Link Between Secondhand Smoke And Cancer
A large-scale study found no clear link between secondhand smoke and lung cancer, undercutting the premise of years of litigation including a Florida case that yielded a $350 million settlement.
First In-Human Trial of Endoxifen Shows Promise as Breast Cancer Treatment
ROCHESTER, Minn. -- A Phase I trial of endoxifen, an active metabolite of the cancer drug tamoxifen, indicates that the experimental drug is safe, with early evidence for anti-tumor activity, a Mayo Clinic study has found.
Tue Dec 10, 2013
Kite Pharma, Inc.'s Lead Program With The National Cancer Institute...
In an oral presentation at the 55th ASH Annual Meeting, , MD, from the NCI reported that an infusion of patients' own genetically modified T lymphocytes resulted in six complete remissions and six partial remissions among 13 patients with advanced B-cell malignancies who were eligible for response assessment.
Mon Dec 09, 2013
Reduced microbiota diversity linked to colorectal cancer risk: Study
A decreased diversity of microbes found in the human gut microbiota is associated with an increased risk of colorectal cancer, say researchers.
Breast cancer prognosis associated with oncometabolite accumulation
The metabolic profile of cancer cells can be used to develop therapies and identify biomarkers associated with cancer outcome.
Sat Dec 07, 2013
Kite Pharma's Lead Program with the National Cancer Institute...
Kite Pharma's Lead Program with the National Cancer Institute Demonstrates Positive Results in Patients with Aggressive Non-Hodgkin's Lymphoma /PRNewswire/ -- Kite Pharma, Inc. , a clinical-stage biotechnology company focused on engineered autologous T cell therapy products for cancer, today announced positive clinical data demonstrating that ... (more)
Fri Dec 06, 2013
New study may change how prostate cancer is treated
Due to promising preliminary results, officials at the National Cancer Institute decided to release them early on December 5 before a full analysis of the trial was completed Due to promising preliminary results, officials at the National Cancer Institute decided to release them early on December 5 before a full analysis of the trial was completed ... (more)
National Cancer Institute Awards Labcyte $1 Million for Novel...
Labcyte, Inc. , an acoustic dispensing company, has been awarded $1 million to create an innovative process to detect cancer-related proteins in samples, with initial work in breast cancer detection.
Lake Elsinore Valley News
Celebrate the rise in cancer survivors
RIVERSIDE COUNTY Not so long ago, a cancer diagnosis was equal to a death-sentence.
Spectrum Pharmaceuticals Highlights 13 Abstracts at the 55th Annual...
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced key presentations of clinical and scientific data at the 55th Annual Meeting of the American Society of Hematology , being held in New Orleans, Louisiana, from December ... (more)
Thu Dec 05, 2013
National Institutes of Health
NIH-funded study shows increased survival in men with metastatic...
Men with hormone-sensitive metastatic prostate cancer who received the chemotherapy drug docetaxel given at the start of standard hormone therapy lived longer than patients who received hormone therapy alone, according to early results from a National Institutes of Health-supported randomized controlled clinical trial.
View Press Release
The CEO Roundtable on Cancer has awarded the North Dakota State College of Science with CEO Cancer Gold Standard TM accreditation for its efforts to reduce the risk of cancer for its employees and covered family members by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality ... (more)
Tue Dec 03, 2013
Breast cancer risk for teenagers who eat too much junk food
Scientists found a strong link between the intake of high fat foods during puberty and the speed at which cancerous cells develop Scientists, funded by the National Cancer Institute, found a strong link between the intake of high fat foods during puberty and the speed at which cancerous cells develop.
Fri Nov 29, 2013
North Country Now
Claims on pill unfounded
In response to "Abortion, Pill Increases Risk, Resident Claims," I attempted to check the claims made in this letter to the editor claiming causal links between abortion, birth control, and breast cancer with information from the Mayo Clinic and the National Cancer Institute at www.cancer.gov .
Fri Nov 22, 2013
Step away from that soda: Sugary drinks raise cancer risk for women, study finds
A customer walks past a shelf of soft drinks in Bangkok. A new study links sugar-sweetened sodas with endometrial cancer.